Current status of islet xenotransplantation

International Journal of Surgery

Volumn 23, Issue , 2015, Pages 261-266

  Park, Chung Gyu ^a,b   Bottino, Rita ^c   Hawthorne, Wayne J ^d,e  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c ALLEGHENY HEALTH NETWORK   (United States)

^d Westmead Institutes for Hlth Res   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Hyperacute rejection; Instant blood mediated inflammatory reaction; Islet transplantation; Neonatal islet cell clusters; Thrombosis; Type 1 diabetes; Xenotransplantation

Indexed keywords

ABATACEPT; ALGINIC ACID; ANTIBODY; BELATACEPT; CD154 ANTIBODY; CLOPIDOGREL; COBROTOXIN; COMPLEMENT FACTOR H; DEXTRAN; EFALIZUMAB; FINGOLIMOD; HEPARIN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLATE MOFETIL; ODULIMOMAB; PIG INSULIN; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANTIBODY RESPONSE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DIABETIC PATIENT; DONOR; GENETIC ENGINEERING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PIG; PRIORITY JOURNAL; REVIEW; XENOTRANSPLANTATION; ANIMAL; DIABETES MELLITUS, TYPE 1; PRIMATE; PROCEDURES; XENOGRAFT;

ANIMALS; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; PRIMATES; SWINE; TISSUE DONORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84951574127     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.07.703     Document Type: Review

References (34)

1. Katagi M., Terashima T., Okano J., Urabe H., Nakae Y., Ogawa N., et al. Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy. FEBS Lett. 2014, 588(6):1080-1086.
2. Babizhayev M.A., Lankin V.Z., Savel'Yeva E.L., Deyev A.I., Yegorov Y.E. Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants. Recent Pat. Drug Deliv. Formul. 2013, 7(3):216-256.
3. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000, 343(4):230-238.
4. Groth C.G., Korsgren O., Tibell A., Tollemar J., Moller E., Bolinder J., et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994, 344(8934):1402-1404.
5. Valdes-Gonzalez R.A., Dorantes L.M., Garibay G.N., Bracho-Blanchet E., Mendez A.J., Davila-Perez R., et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur. J. Endocrinol. 2005, 153(3):419-427.
6. Wang W., Mo Z., Ye B., Hu P., Liu S., Yi S. A clinical trial of xenotransplantation of neonatal pig islets for diabetic patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011, 36(12):1134-1140.
7. Hering B.J., Wijkstrom M., Graham M.L., Hardstedt M., Aasheim T.C., Jie T., et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat. Med. 2006, 12(3):301-303.
8. Cardona K., Korbutt G.S., Milas Z., Lyon J., Cano J., Jiang W., et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat. Med. 2006, 12(3):304-306.
9. Shin J.S., Kim J.M., Kim J.S., Min B.H., Kim Y.H., Kim H.J., et al. Long-term control of diabetes in immunosuppressed nonhuman primates (NHP) by the transplantation of adult porcine islets. Am. J. Transpl. 2015, Jun 10. 10.1111/ajt.13345.
10. van der Windt D.J., Bottino R., Casu A., Campanile N., Smetanka C., He J., et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am. J. Transpl. 2009, 9(12):2716-2726.
11. Thompson P., Badell I.R., Lowe M., Cano J., Song M., Leopardi F., et al. Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am. J. Transpl. 2011, 11(12):2593-2602.
12. Bottino R., Wijkstrom M., van der Windt D.J., Hara H., Ezzelarab M., Murase N., et al. Pig-to-monkey islet xenotransplantation using multi-transgenic pigs. Am. J. Transpl. 2014, 14(10):2275-2287.
13. Hawthorne W.J., Salvaris E.J., Phillips P., Hawkes J., Liuwantara D., Burns H., et al. Control of IBMIR in neonatal porcine islet xenotransplantation in baboons. Am. J. Transpl. 2014, 14(6):1300-1309.
14. Thompson P., Badell I.R., Lowe M., Turner A., Cano J., Avila J., et al. Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival. Am. J. Transpl. 2012, 12(7):1765-1775.
15. Major E.O. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 2010, 61:35-47.
16. Thompson P., Cardona K., Russell M., Badell I.R., Shaffer V., Korbutt G., et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am. J. Transpl. 2011, 11(5):947-957.
17. Lowe M., Badell I.R., Thompson P., Martin B., Leopardi F., Strobert E., et al. A novel monoclonal antibody to CD40 prolongs islet allograft survival. Am. J. Transpl. 2012, 12(8):2079-2087.
18. Mohiuddin M.M., Singh A.K., Corcoran P.C., Hoyt R.F., Thomas M.L., Lewis B.G., et al. One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am. J. Transpl. 2014, 14(2):488-489.
19. Iwase H., Ekser B., Satyananda V., Bhama J., Hara H., Ezzelarab M., et al. Pig-to-baboon heterotopic heart transplantation - exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens. Xenotransplantation 2015, 22(3):211-220.
20. Sun Y., Ma X., Zhou D., Vacek I., Sun A.M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Investig. 1996, 98(6):1417-1422.
21. Dufrane D., Goebbels R.M., Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010, 90(10):1054-1062.
22. Dufrane D., Goebbels R.M., Saliez A., Guiot Y., Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006, 81(9):1345-1353.
23. Bottino R., Balamurugan A.N., Smetanka C., Bertera S., He J., Rood P.P., et al. Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation 2007, 14(1):74-82.
24. Dufrane D., D'Hoore W., Goebbels R.M., Saliez A., Guiot Y., Gianello P. Parameters favouring successful adult pig islet isolations for xenotransplantation in pig-to-primate models. Xenotransplantation 2006, 13(3):204-214.
25. Rajotte R.V. Isolation and assessment of islet quality. Xenotransplantation 2008, 15(2):93-95.
26. Hecht G., Eventov-Friedman S., Rosen C., Shezen E., Tchorsh D., Aronovich A., et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(21):8659-8664.
27. Eventov-Friedman S., Tchorsh D., Katchman H., Shezen E., Aronovich A., Hecht G., et al. Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. PLoS Med. 2006, 3(7):e215.
28. Diswall M., Angstrom J., Schuurman H.J., Dor F.J., Rydberg L., Breimer M.E. Studies on glycolipid antigens in small intestine and pancreas from alpha1,3-galactosyltransferase knockout miniature swine. Transplantation 2007, 84(10):1348-1356.
29. Choi H.J., Lee J.J., Kim D.H., Kim M.K., Lee H.J., Ko A.Y., et al. Blockade of CD40-CD154 costimulatory pathway promotes long-term survival of full-thickness porcine corneal grafts in nonhuman primates: clinically applicable xenocorneal transplantation. Am. J. Transpl. 2015, 15(3):628-641.
30. Casu A., Echeverri G.J., Bottino R., van der Windt D.J., He J., Ekser B., et al. Insulin secretion and glucose metabolism in alpha 1,3-galactosyltransferase knock-out pigs compared to wild-type pigs. Xenotransplantation 2010, 17(2):131-139.
31. Wijkstrom M., Bottino R., Iwase H., Hara H., Ekser B., van der Windt D., et al. Glucose metabolism in pigs expressing human genes under an insulin promoter. Xenotransplantation 2015, 22(1):70-79.
32. Kirchhof N., Shibata S., Wijkstrom M., Kulick D.M., Salerno C.T., Clemmings S.M., et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004, 11(5):396-407.
33. Kang H.J., Lee H., Park E.M., Kim J.M., Shin J.S., Kim J.S., et al. Dissociation between anti-porcine albumin and anti-gal antibody responses in non-human primate recipients of intraportal porcine islet transplantation. Xenotransplantation 2015, 22(2):124-134.
34. Li S., Yan Y., Lin Y., Bullens D.M., Rutgeerts O., Goebels J., et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 2007, 110(12):3926-3935.